RU
Pulmonology
Respium®
Registration certificate:
LP-006263
INN:
Tiotropium Bromide
Release form:
Inhalation powder hard capsule
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
M-holinoblocker
Conditions for dispensing:
On prescription
Leaflet:
ОХЛП Респиум.pdf
520kb
Packaging:

Indications:

Tiotropium Bromide is indicated for maintenance therapy in patients with COPD, including chronic bronchitis and emphysema (maintenance therapy to alleviate persistent dyspnea and prevent exacerbations).

This medication is included in the List of Essential Medicines.

Using Respium®
 
Quality control
at all stages of production